Home › Funds › Aristotle Atlantic Partners, LLC › DXCM
Aristotle Atlantic Partners, LLC position in DXCM
DEXCOM INC · Health Care
Aristotle Atlantic Partners, LLC reported holding 528,767 shares of DXCM (DEXCOM INC) in its Q3 2026 13F filing — a position valued at US$45.6M, representing 1.78% of its reported portfolio and ranking #18 among its reported holdings. Aristotle Atlantic Partners, LLC has disclosed DXCM holdings in 10 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Aristotle Atlantic Partners, LLC's DXCM position evolved
Aristotle Atlantic Partners, LLC first disclosed a stake in DXCM in Q3 2023 at 200,831 shares (US$18.7M). The position peaked in Q3 2026 at 528,767 shares, worth US$45.6M. Across 10 filings, Aristotle Atlantic Partners, LLC increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 528,767 shares valued at US$45.6M — an increase of 179,350 shares quarter over quarter.. Notable position changes include a 39% increase in Q2 2026 (shares rose 28% over the following quarter), a 51% increase in Q3 2026 (shares fell 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 200.83K | $18.74M | New |
| Q4 2023 | 203.15K | $25.21M | Add |
| Q1 2024 | 200.46K | $27.80M | Reduce |
| Q2 2024 | 199.25K | $22.59M | Reduce |
| Q3 2024 | 199.44K | $13.37M | Hold |
| Q3 2025 | 193.28K | $13.01M | New |
| Q4 2025 | 235.61K | $15.64M | Add |
| Q1 2026 | 251.49K | $15.79M | Add |
| Q2 2026 | 349.42K | $23.53M | Add |
| Q3 2026 | 528.77K | $45.63M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DXCM and 13F data
DXCM (DEXCOM INC) is a Health Care company. 31 other funds we track also report a position in DXCM — the largest reported positions include Baillie Gifford & Co (US$1.25B), Castle Hook Partners LP (US$260.7M), Employees Provident Fund Board (US$189.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DXCM
- Baillie Gifford & Co 14.52M sh · $1.25B · Q3 2026
- Castle Hook Partners LP 3.87M sh · $260.67M · Q2 2026
- Employees Provident Fund Board 2.19M sh · $188.98M · Q3 2026
More on Aristotle Atlantic Partners, LLC
FAQ
How long has Aristotle Atlantic Partners, LLC held DXCM?
Aristotle Atlantic Partners, LLC has disclosed DXCM holdings in 10 of the last 13 reported quarters, going back to Q3 2023.
What is Aristotle Atlantic Partners, LLC's current position in DXCM?
As of Q3 2026, Aristotle Atlantic Partners, LLC holds 528.77K shares of DXCM (DEXCOM INC), valued at $45.63M, representing 1.78% of its reported portfolio and ranking #18.
Has Aristotle Atlantic Partners, LLC been buying or selling DXCM?
In the latest 13F filing (Q3 2026), Aristotle Atlantic Partners, LLC increased its position in DXCM. The position peaked in Q3 2026 at 528.77K shares.
Which other funds hold DXCM?
Other major institutional holders of DXCM include Baillie Gifford & Co, Castle Hook Partners LP, Employees Provident Fund Board, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.